AUROBINDO PHARMA
Back to Income Statement
|
AUROBINDO PHARMA Last 5 Year Total Expenditure History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Expenditure | ₹25,141 Cr | ₹23,159 Cr | ₹21,137 Cr | ₹19,071 Cr | ₹19,441 Cr |
What is the latest Total Expenditure of AUROBINDO PHARMA ?
| Year | Total Expenditure |
|---|---|
| Mar2025 | ₹25,141 Cr |
| Mar2024 | ₹23,159 Cr |
| Mar2023 | ₹21,137 Cr |
| Mar2022 | ₹19,071 Cr |
| Mar2021 | ₹19,441 Cr |
How is Total Expenditure of AUROBINDO PHARMA Trending?
| Years | Total Expenditure | % Change | |
|---|---|---|---|
| Mar2025 | ₹25,141 Cr | 8.56 | |
| Mar2024 | ₹23,159 Cr | 9.57 | |
| Mar2023 | ₹21,137 Cr | 10.83 | |
| Mar2022 | ₹19,071 Cr | -1.90 | |
| Mar2021 | ₹19,441 Cr | - | |
Compare Total Expenditure of peers of AUROBINDO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AUROBINDO PHARMA | ₹67,791.0 Cr | -0.5% | -2.2% | -0.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹401,541.0 Cr | -3.6% | -6.8% | -5.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹163,031.0 Cr | -5.4% | -2.4% | 3.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹138,451.0 Cr | 3.6% | 8.5% | 23.5% | Stock Analytics | |
| CIPLA | ₹112,377.0 Cr | -5.1% | -7.1% | -3.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,355.5 Cr | -4.1% | -8.3% | -12.1% | Stock Analytics | |
AUROBINDO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AUROBINDO PHARMA | -0.5% |
-2.2% |
-0.2% |
| SENSEX | -0.4% |
-1.7% |
9.1% |
You may also like the below Video Courses